College Directory

    Deborah German, M.D.
  • Title: Vice President for Medical Affairs and Dean
  • Office: College of Medicine, 3rd Floor
  • Phone: 407.266.1000
  • Send an Email
  • Education:
    • B.S. Chemistry, Boston University
    • M.D., Harvard Medical School
    • Resident in Medicine, Strong Memorial Hospital, Rochester, New York
  • Biography:

    Dr. German was appointed Founding Dean of the University of Central Florida College of Medicine in December 2006. She also serves as UCF’s Vice President for Medical Affairs.

    As such, she oversees both the Medical Education (M.D.) program and the Burnett School of Biomedical Sciences.

    Under Dr. German’s leadership, the College of Medicine:

    • Achieved full accreditation from the Liaison Committee on Medical Education
    • Raised funds to provide full four-year scholarships for the entire Charter class
    • Built a team of over 500 faculty and staff
    • Appointed over 2,000 volunteer and affiliated faculty
    • Oversaw construction of 375,000 square feet of medical school space the emerging Medical City at Lake Nona, located 25 minutes from the UCF main campus.

    Deborah German earned her undergraduate degree in chemistry at Boston University and gained her M.D. degree from Harvard Medical School.

    She was a Resident in Medicine at the University of Rochester in New York. After her residency, she became a Fellow in Rheumatic and Genetic Diseases at Duke University in Durham, North Carolina. She was appointed to the faculty at Duke University Medical School and worked in the Howard Hughes Medical Institute, studying adenosine metabolism.

    She was also Director of the Duke Gout Clinics and Associate Dean of Medical Education while maintaining her own private practice of Internal Medicine and Rheumatology.

    In 1988, Dr. German joined Vanderbilt University, Nashville, Tennessee, as Associate Dean for Students and later Senior Associate Dean of Medical Education. She was also the National Chair for the Association of American Medical Colleges’ Group on Student Affairs.

    While in Nashville, Dr. German served on the Board of Trustees of the Tennessee Medical Association. She also chaired the Tennessee Board of Directors for the Arthritis Foundation.

    After 13 years at Vanderbilt, Dr. German next served as President and Chief Executive Officer at Saint Thomas Hospital in Nashville. She was also Senior Vice President and Chief Academic Officer for Saint Thomas Health Services. Dr. German led a successful hospital turnaround and initiated service excellence and quality programs at the hospital that received national recognition. Throughout this time she continued to practice medicine.

    In 2005, Dr. German spent a year at the Association of American Medical Colleges in Washington, D.C. as a Petersdorf Scholar in Residence. She studied the leadership of academic health centers framed in the concepts of chaos theory and complex adaptive system science.

    Many communities have recognized Dr. German for her contributions. The city of Nashville honored her with the Athena Award and she was inducted into the YWCA Academy for Women of Achievement. She is the recipient of the AAMC Women in Medicine Leadership Development Award. Dr. German was named a Local Legend of Medicine in the National Library of Medicine.

    In Florida, Dr. German was awarded both the 2008 Business Executive of the Year and 2008 Businesswoman of the Year by co-sponsors Orlando Business Journal and Orlando Health. In addition, Dr. German was recognized by the Orlando Sentinel’s Editorial Board as 2008 Central Floridian of the Year.

    Dr. German is the mother of two daughters and has one grandson.

View Full Profile
    Juan C. Cendán, M.D., Chair
  • Title: Chair, Medical Education, Assistant Dean for Simulation and Professor of Surgery
  • Office: College of Medicine, 4th Floor
  • Phone: 407.266.1141
  • Send an Email
  • Education:
    • B.S., Magna Cum Laude, Biomedical Engineering, Tulane University, New Orleans, Louisiana
    • M.D., University of Florida, Gainesville, Florida
    • Resident, Surgery, University of Florida, Gainesville, Florida
    • Research Fellow, Surgical Metabolism Laboratory, University of Florida, Gainesville, Florida
    • Master Educator, Medical Education, University of Florida, Gainesville, Florida


    • Surgery
    • Minimally Invasive Surgery
  • Biography:

    Dr. Cendán joined the University of Central Florida College of Medicine in July 2010 as a Founding Faculty member. His initial efforts were aimed at developing the Clinical Skills and Simulation Center, which he led as medical director until January 2015. He remains the Assistant Dean for Simulation although his leadership role as Chairman of the Department of Medical Education has now become a focal part of his work. He leads a department of twenty faculty members whose primary mission is to support the undergraduate medical education program at UCF-COM.

    Dr. Cendán is a board-certified surgeon with a clinical focus on minimally invasive surgery and surgical disorders of the breast. His special interests include medical education and simulation. Dr. Cendán is an active researcher whose laboratory has active R01 grant funding from the National Institute of Health, the National Science Foundation and the Macy Foundation.



    For a complete list of publications please click here.

View Full Profile
    Diane D. Davey, M.D.
  • Title: Associate Dean, Graduate Medical Education, Professor of Pathology
  • Office: College of Medicine, 4th Floor
  • Phone: 407.266.1100
  • Send an Email
  • Education:
    • B.S. Cornell University
    • B.S. Medicine, University of South Dakota
    • M.D. Washington University, St. Louis
    • Residency in Pathology Indiana University Medical Center
    • Residency in Pathology University of Iowa
    • Fellowship in Hematopathology, University of Iowa


    • Pathology (Cytopathology and Hematopathology)

    Research Interests:

    • Cervical cytology
    • Quality improvement efforts in cytology
    • New cytology laboratory technologies and patient management guidelines
    • Graduate medical education
  • Biography:


    Diane Davis Davey is Professor of Pathology, Associate Dean for Graduate Medical Education, and Designated Institutional Official (DIO). She is also a part-time pathologist at the Orlando Veterans Affairs Medical Center with specialty expertise in cytopathology and hematopathology. She chairs the Graduate Medical Education Committee and is involved with efforts to build new residency programs in Central Florida. Dr. Davey is a Past-President of the College of Medicine Faculty Council, served as Interim Chair of the Clinical Sciences Department in 2015-16, and is a member of COM Enterprise. Dr. Davey teaches in several medical student modules including the S1 Hematology/Oncology module.

    Prior to coming to Florida in late 2007, Dr. Davey was Vice Chair for Education in the Department of Pathology and Laboratory Medicine at the Univ. of Kentucky. She also directed the cytopathology fellowship program and the cytology and bone marrow laboratories at the University of Kentucky. Diane received her M.D. at Washington University and did her pathology residency at Indiana University and the University of Iowa. She completed a hematopathology fellowship at the University of Iowa. She is board-certified in anatomic and clinical pathology, hematology and cytopathology by the American Board of Pathology.

    Diane is a current member and past-chair of the College of American Pathologists Cytopathology Committee. She is a member of the American Society of Cytopathology (ASC) Awards Committee as well as the Position Statement and Guidelines Review Committee. She is a Past-President and Trustee of the American Board of Pathology, the certifying board for pathologists, and a past member of the Pathology Residency Review Committee for the Accreditation Council for Graduate Medical Education. She was President of the American Society of Cytopathology in 2001-2, and she served as a moderator for the National Cancer Institute (NCI) Bethesda 2001 Workshop for Cervical Cytology terminology. She has served on several committees of both the American Society for Colposcopy and Cervical Pathology, and has worked on task forces to develop management guidelines for cervical cancer screening.

    She has been an advisor for both the FDA and the NCI, and serves on editorial boards for four journals. Her research efforts have focused on cervical cytology and quality improvement efforts in laboratories, including uniform reporting terminology, new cytology laboratory technologies, and laboratory and patient management guidelines, and more recently on educational and competency assessment.



    Davey DD, Goulart R, Nayar R, on behalf of the Cytopathology Education and Technology Consortium (CETC). 2013 statement on human papillomavirus test utilization. Cancer (Cancer Cytopathol) 2014;122:83-6, PMID::23861330 (early online publication). Also published in Acta Cytologica, Diagnostic Cytopathology, Journal of the ASC, American Journal of Clinical Pathology.

    Davey DD, Austin RM, Birdsong G, Zaleski S. The impact of the Clinical Laboratory Improvement Amendments of 1988 on cytopathology practice: a 25th anniversary review. J Am Soc Cyto 2014: 3:188-198

    Davey DD, Kaplan DR, Michael CW. Strong performance on the Progressive Evaluation of Competency fellowship final examination predicts American Board of Pathology Certification. J Am Soc Cyto 2014; 3:269-73 (Sept) (early online publication).

    Johnson J, Khalil M, Peppler R, Davey D, Kibble J. Use of the NBME Comprehensive Basic Science Examination as a progress test in the pre-clerkship curriculum of a new medical school. Adv Physiol Educ 2014 38:315-20 (Dec) (PMID: 25434014).

    Nayar R, Goulart RA, Tiscornia-Wasserman PG, Davey DD. Primary human papillomavirus screening for cervical cancer in the United States—US Food and Drug Administration Approval, clinical trials, and where we are today. Cancer (Cancer Cytopathol) 2014 (October); 122:720-729 (PMID: 25228434).

    Huh WK, Ault K, Chelmow D, Davey DD, Goulart RA, et al. Use of primary high risk papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol 2015; 136:178-182 (Feb) (PMID 25579107). Published simultaneously in: J Lower Genit Tract Dis 2015;19:91-96 (Apr) (PMID:25574659), Obstet Gynecol 2015;125:330-337 (Feb) (PMID: 25569009)

    Birdsong G, Davey DD. “Specimen Adequacy”. In: Edited by Nayar R and Wilbur DC. The Bethesda System for Reporting Cervical Cytology. Definitions, Criteria, and Explanatory Notes. Third Edition. Springer International Publishing, Switzerland, 2015.

    Zhao C, Crothers BA, Ghofrani, M, Li Z, Souers, RJ,  Husain, M,  Fan F, Ocal IT, Goodrich K, Shen R, Davey DD. Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey. Arch Pathol Lab Med 2016; 140:1364-70. PMID 27479334

    Zhao C, Crothers BA, Ghofrani, M, Li Z,  Souers, RJ, Husain, M,  Fan F, Ocal IT, Davey DD. Misinterpretation Papanicolaou Test Rates of high-grade squamous intraepithelial lesion in the College of American Pathologists Gynecologic PAP Education and PAP Proficiency Test Program. Arch Pathol Lab Med 2016;140:1221-4. PMID: 27662094

    Ghofrani M, Zhao C, Davey DD, Fan F, Husain M, Laser A, Ocal IT, Shen RZ, Goodrich K, Souers RJ, Crothers, BA. Update on the College of American Pathologists’ Experience with High-Risk Human Papillomavirus Proficiency Testing for Cytology. Arch Pathol Lab Med 2016;140:1371-4. PMID 27557412


    • 1999-2000 Women of Achievement of the A.B. Chandler Medical Center
    • 2001 William L. Kuehn, Ph.D., Outstanding Communicator Award, College of American Pathologists
    • 2002 Elected as Trustee, American Board of Pathology
    • 2005-2015 Named to Best Doctors of America
    • 2007 University of Iowa Department of Pathology Distinguished Achievement Award
    • 2007 Papanicolaou Award, American Society of Cytopathology
    • 2008 American Society for Colposcopy and Cervical Pathology Award of Merit
    • 2011 Elected to President, American Board of Pathology
    • 2011 Lifetime Achievement Award, College of American Pathologists
View Full Profile
    Dr. Steven Ebert
  • Title: Associate Professor and Immediate Past President, College of Medicine Faculty Council
  • Office: BBS 421
  • Phone: 407.266.7047
  • Send an Email
  • Biography:
    Cardiovascular disease is the leading cause of death in the United States. In addition, congenital heart disease occurs in 0.4-1.2% of all live births, and is a suspected leading cause of miscarriages. Consequently, gaining an understanding of the molecular signaling events that regulate cardiovascular development is of critical importance.Catecholamine hormones, such as epinephrine and/or norepinephrine, are produced locally within the developing heart to stimulate cardiac beating activity.
    In adult mammals, the heart is exposed to epinephrine following its secretion into the bloodstream from the adrenal gland, and norepinephrine following sympathetic nerve activation. Both catecholamines strongly stimulate the rate and force of cardiac contractions, thereby increasing cardiac output during stressful events. Our work has shown that the embryonic heart itself is capable of producing these hormones/neurotransmitters beginning at about the time that the heart first starts to beat. This intrinsic cardiac production of catecholamines precedes any innervation of the heart and occurs several days before the adrenal gland is even formed. Thus, local production of catecholamines by the embryonic heart may provide a stimulus for the development of cardiac function.We use a variety of molecular and cellular biology techniques together with in vivo imaging, electrophysiological, and genetic engineering approaches to study the role of catecholamine hormones and the cells that produce them in the developing heart from early embryological stages into adulthood.
    Recent Publications
    1. Baker CN, Katsandris R, Van C, and Ebert SN (2014) Adrenaline and Stress-Induced Cardiomyopathies: Three Competing Hypotheses for Mechanism(s) of Action. Chapter 4 (pp. 81-116) in book entitled, “Adrenaline: Production, Role in Disease and Stress, Effects on the Mind and Body”. Alfred Bennun, Editor. Nova Scientific Publishers, Inc.
    2. Varudkar N, Emrani H, Ebert SN, and Madan A (2014) Endothelial dysfunction and cardiovascular disease: Critical target for cell-based therapies. British Journal of Medicine and Medical Research 4:3042-3058.
    3. Baker CN and Ebert SN (2013) Development of aerobic metabolism in utero: requirement for mitochondrial function during embryonic and foetal periods. OA Biotechnology 2:16.
    4. Owji A, Varudkar N, and Ebert SN (2013) Therapeutic potential of Pnmt+ primer cells for neuro/cardio regeneration. American Journal of Stem Cells 2:137-54.
    5. Xia J, Varudkar N, Baker C, Abukenda I, Martinez C, Natarajan A, Grinberg A, Pfeifer K, and Ebert SN (2013) Targeting of the Enhanced Green Fluorescent Protein Reporter to Adrenergic Cells in Mice. Molecular Biotechnology 54:350-60.
    6. Osuala K, Baker C, Nguyen HL, Martinez C, Weinshenker D, and Ebert SN (2012) Physiological and genomic consequences of adrenergic deficiency during embryonic/fetal development in mice: impact on retinoic acid metabolism. Physiological Genomics 44:934-947.
    7. Baker CN, Taylor DG, Osuala K, Natarajan A, Molnar PJ, Hickman J, Alam S, Moscato B, Weinshenker D, and Ebert SN (2012) Adrenergic Deficiency Leads to Impaired Electrical Conduction and Increased Arrhythmic Potential in the Embryonic Mouse Heart.Biochemical and Biophysical Research Communications 423: 536-41.
    8. Ebert SN (2012) Tbx3: A new trick for an old myocyte? Cardiovascular Research 94:398-9.
    9. Sharara-Chami RI, Zhou Y, Ebert S, Pacak K, Ozcan U, and Mazjoub JA (2012) Epinephrine Deficiency Results In Intact Glucose Counter-Regulation, Severe Hepatic Steatosis And Possible Defective Autophagy In Fasting Mice. The International Journal of Biochemistry & Cell Biology44:905-13.
    10. Osuala K, Telusma K, Khan SM, Wu S, Shah M, Baker C, Alam S, Abukenda I, Fuentes A, Seifein HB, Ebert SN (2011) Distinctive left-sided distribution of adrenergic-derived cells in the adult mouse heart.  PLoS One 2011;6(7):e22811.
    11. Xia J, Martinez A, Daniell H, and Ebert SN (2011) Evaluation of biolistic gene transfer methods in vivo using non-invasive bioluminescent imaging techniques. BMC Biotechnology 11:62.
    12. Sharara-Chami RI, Joachim M, Mulcahey M, Ebert S, Majzoub JA (2010) Effect of epinephrine deficiency on cold tolerance and on brown adipose tissue. Mol Cell Endocrinol. 328:34-9.
    13. Lymperopoulos A, Rengo G, Gao E, Ebert SN, Dorn GW 2nd, Koch WJ (2010) Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction. J Biol Chem. 285:16378-86.
    14. Kamilli RK, Taylor DG, Osuala K, Thompson K, Menick DR, and Ebert SN (2010) Generation of novel reporter stem cells and their application for molecular imaging of cardiac-differentiated stem cells in vivo. Stem Cells & Development 19:1437-1448.(COVER ILLUSTRATION)

    For more publication information, please visit Pubmed.

View Full Profile
    Dr. Cristina Fernandez-Valle
  • Title: Professor, Neuroscience Division Head, Vice President College of Medicine Faculty Council
  • Office: BBS 249
  • Phone: 407.266.7033
  • Send an Email
  • Biography:

    My research is focused on understanding molecular mechanisms controlling peripheral nerve development with emphasis on regulation of growth and differentiation of Schwann cells into myelin-forming cells. Major pathways examined are transduction of extracellular matrix signals through integrin receptors and neuregulin signalling through erbB2/erbB3 receptors. The integration of these pathways with those regulating cytoskeleton organization through the rho family of GTPases is under study.

    We have found that schwannomin/merlin the product of the Neurofibromatosis type 2 gene is a direct binding protein with paxillin, an integrator of extracellular matrix and growth factor signalling with changes in the actin cytoskeleton. The interacting domain in schwannomin is mutated in humans with NF2 mutations and leads to tumor formation.

    The studies are conducted using primary Schwann cells in isolation or together with sensory neurons to study development of myelin in vitrol. These studies are funded by a long-standing grant from NIH/NINDS and have application for the understanding of various demyelinating diseases as well as abnormal growth of Schwann cells.
    Recent Publications

    1. Sparrow N*, Manetti M, Bott M, Bates, M, Bunge MB, Lambert, S, Fernandez-Valle C.  (2012) The Actin Severing Protein Cofilin is Downstream of Neuregulin Signaling and is Essential For Schwann Cell Myelination. J Neuroscience. 32:5284-97.
    2. Douglass. Sparrow, Bott, Fernandez-Valle, Dogariu. 2012Measuring Anisotropic Cell Motility on Curved Substrates. J Biophotonics (doi: 10.1002/jbio.201200089.)
    3. Manetti, Geden, Bott, Sparrow, Lambert, Fernandez Valle. 2012 Stability of the tumor suppressor merlin depends on its ability to bind paxillin LD3 and associate with β1 integrin and actin at the plasma membrane.   Biology Open (doi: 10.1242/bio.20122121; 1, 949-957.)
    4. Thaxton C*, Bott M, Walker B, Sparrow NA*, Lambert S, and Fernandez-Valle C.  2011. Schwannomin Promotes Process Extension and Determines Internodal Myelin Length. Mol Cell Neuroscience. 47:1-9.
    5. Iacovelli J, Lopera J, Bott M, Baldwin ME, Khaled A, Uddin N, Fernandez-Valle C (2007). Serum and forskolin cooperate to promote G1 progression in Schwann cells by differentially regulating cyclin D1, cyclin E1, and p27Kip expression. Glia 55(16):  1638-47.
    6. Thaxton C, Lopera J, Bott M, Fernandez-Valle C (2007) Neuregulin and laminin stimulate phosphorylation of the NF2 tumor supressor in Schwann cells by distinct protein kinase A and p21-activated kinase-dependent pathways.  Oncogene. doi: 10.1038/sj.onc.1210923.

    For more publication information, please visit Pubmed.

View Full Profile
    Jane S. Gibson, Ph.D., Chair
  • Title: Chair, Clinical Sciences, Professor of Pathology
  • Office: College of Medicine, 4th Floor
  • Phone: 407.266.1100
  • Send an Email
  • Education:
    • B.S. Microbiology and Cell Science University of Florida
    • M.S. Medical Sciences/Pathology University of Florida
    • Ph.D. Pathology/Laboratory Medicine University of Florida College of Medicine


    • Molecular Genetics
    • Molecular Pathology
  • Biography:


    Dr. Gibson is currently Professor of Pathology and Chair, Department of Clinical Sciences, and Director of Molecular Diagnostics at the University of Central Florida College of Medicine.  She is board certified by the American Board of Medical Genetics and Genomics (ABMGG), is a fellow of the American College of Medical Genetics (ACMG), and serves as a member of the American Board of Medical Genetics and Genomics Board of Directors. Dr. Gibson received her training at the University of Florida College of Medicine, and her practice includes molecular pathology and molecular genetics.  She has served as the Director of Molecular Genetics for M.D. Anderson Cancer Center Orlando, and later as the  Director of Molecular Genetics and Cytogenetics for AmeriPath, Inc. (A Division of  Quest Diagnostics).  She participates in a number of national-level professional activities including serving as Chair of the Association for Molecular Pathology (AMP) Publications and Communications Committee and member of the AMP Board of Directors. She is on the editorial board for the Journal of Molecular Diagnostics, and has authored a number of book chapters, articles and published abstracts in the fields of molecular pathology and genetics, and has been the principle investigator for numerous clinical trials.




    Sarosdy, M., Kahn, P. Ziffer M., Love, W., Barkin J., Abara, E. Jansz, K., Bridge, J., Johansson, S., Persons, D., and Gibson, J. Use of a mutitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria J Urol 2006 Jul;176(1):44-7 Gibson, J.S., et al. The Roche AMPLICOR HPV Test as a primary screen for HPV in cervical specimens collected in ThinPrep and SurePath liquid cytology media. 21st International Papilloma Conference Proceedings 2004: 261

    Gibson, J.S. Vinson, D., Flynn, D., Hernandez S., Bolick, D., Juretich, M., Kosarikov, D., Bui, L., and Sun, R. Evaluation Of The Roche Prototype Line-Blot (LBA) Assay For Detection And Genotyping Of High-Risk HPV From Specimens Collected In Sure-Path and Thin-Prep Liquid Cytology Medias. American Society of Cytopathology Annual Meeting, November 2003.

    Chakrabarti, R., Robles, L.D., Gibson, J., and Muroski, M. Profiling Of Differential Expression Of Messenger RNA In Normal, Benign, And Metastatic Prostate Cell Lines. Cancer Genet Cytogenet. 139: 115-25, 2002.

View Full Profile
    Marcia Katz, M.D.
  • Title: Associate Dean for Clinical Affairs
  • Office: COM 312L
  • Phone: 407.266.1051
  • Send an Email

  • If you are a UCF Health patient of this physician and wish to communicate with them, please use the patient portal.
  • Patient Practice
  • Education:

    Dr. Katz received her M.D. at Boston University School of Medicine after earning an undergraduate degree in biology at Brown University. She did her internal medicine residency at Boston City Hospital and her fellowship training in pulmonary and critical care from The Pulmonary Center at Boston University School of Medicine. She served on the center committee of the Cystic Fibrosis Foundation, the governing body that accredits all CF centers.

  • Biography:

    Dr. Marcia Katz is Associate Dean for Clinical Affairs and professor of medicine at the University of Central Florida College of Medicine.

    A practicing pulmonary and critical care physician, Dr. Katz came to UCF in 2016. Prior to that, she served in multiple leadership roles at the Baylor College of Medicine. She was Associate Chair of Medicine for Clinical Affairs, Medical Director of the Department of Medicine for the Faculty Group Practice, and Chief of Adult Medicine at Texas Children’s Hospital/The Pavilion for Women. In her role as Associate Chair, she led the clinical mission of practice sites and affiliated institutions with a renewed focus on patient-centered care with the highest quality and safety. As head of adult medicine at TCH, she planned and helped build the Pavilion for Women, a state-of-the-art 110-bed OB-GYN hospital that opened in 2012.

    She served as medical director of the medical school’s Adult Cystic Fibrosis Center, one of the largest accredited CF centers in the nation. She also served as Co-PI of the Cystic Fibrosis Therapeutic Development Center, the facility’s clinical research arm. A former ELAM (Executive Leadership in Academic Medicine Program for Women) fellow at Drexel University College of Medicine, she holds a graduate certificate in healthcare management from Rice University. She was also honored in 2012 with the Ben and Margaret Love Foundation Bobby R. Alford Award for Academic Clinical Professionalism, the highest award Baylor gives to a medical school faculty member.



    Tang S, Moonnumakal SP, Stevens B, Douglas G, Mason S, Schmitt ES, Eng CM, Katz M, Fang Characterization of a recurrent 3.8 kb deletion involving exons 17a and 17b within the CFTR gene, J Cyst Fibrosis. 2013:12(3):290-4


    Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, Robinson KA, Sabadosa KA, Stecenko A, Slovis B, the CFRD Guidelines Committee. Clinical Care Guidelines for Cystic Fibrosis – Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society, Diabetes Care, 2010 December; 33(12):2697-2708.


    Moskowitz SM, Emerson JC, McNamara S, Shell RD, Orenstein DM, Rosenbluth D, Katz MF, Ahrens R, Hornick D, Joseph PM, Gibson RL, Aitken ML, Benton WW, Burns JL. Randomized Trial of biofilm testing to select antibiotics for cystic fibrosis airway infection, Pediatric Pulmonology, 2010 October 20 (published ahead of print).


    Z Safdar, MF Katz, AE Frost. Computed axial tomography evidence of left atrial enlargement: a predictor of elevated pulmonary capillary wedge pressure in pulmonary hypertension, International Journal of General Medicine, December 2009, Volume 2010:3.


    CM Oermann, C Wheeler, S Cumming, MF Katz. A Pilot Study Evaluating the Potential Use of Low Dose Methotrexate as an Anti-Inflammatory Therapy for CF Lung Disease, Pediatric Pulmonology, Supplement 30, 258, 2007

View Full Profile
    Dr. Griff Parks
  • Title: Director, Burnett School of Biomedical Sciences and Professor
  • Office: BBS 101G
  • Phone: 407.266.7011
  • Send an Email
  • Biography:

    We study the replication and innate immune responses to Paramyxoviruses – a remarkably diverse family of negative-strand RNA viruses, some of which are the most ubiquitous disease-causing viruses of humans and animals. This work includes the development of vectors for therapy or vaccination that are based on novel properties of the viral genomes and proteins. In addition, we have expanded our focus to include viral immunology projects (interferon and complement) with the bioterrorism agent Nipah virus and the pathogenic bunyaviruses.

    Our lab projects can be divided into three general areas:

    1)    Interactions of negative strand RNA viruses with interferon and complement immune pathways. We address the questions of how these viruses first activate and then suppress important innate immune pathways in order to successfully replicate. This involves studies to understand the viral factors that induce interferon and complement responses, as well as the cellular sensors and pathways that respond, suppress replication, and neutralize virus.

    2)    Developing of novel viral vectors for tumor therapy. We are taking advantage of inherent properties of the viruses we study to design novel vectors for controlled killing of tumor cells. This includes modifying the viral glycoproteins to produce vectors with enhanced ability to spread through a population of tumor cells. In addition, viral mutants which are defective in suppression of innate immunity are being tested for their ability to spread in tumor cells while retaining restricted growth in normal cells.

    3)    Development of vaccine vectors based on paramyxoviruses. Viral vectors can be potent inducers of innate and adaptive immunity, but also can cause disease in some cases. We are exploiting unique properties of some of these paramyxoviruses to develop new delivery vehicles that balance attenuated replication with induction of strong immunity to an engineered antigen.

    Recent Publications

    1. Ganguli T, Johnson JB, Parks GD and Deora R. 2014. Bordetella BPS interactions with human complement pathways. Cellular Microbiol 16:1105-1118.
    2. Mayer AE, Johnson JB, and Parks GD. 2014. The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African Green monkeys is dependent on complement. Virology 460:23-33.
    3. Khalil SM, Tonkin DR, Snead AT, Parks GD, Johnston RE, and White LJ. 2014. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells and protective immunity to influenza virus in neonatal mice. J. Virol. 88:9182-9196.
    4. Johnson JB, Schmitt AP, and Parks GD. 2013. Point mutations in the paramyxovirus F protein that enhance fusion activity shift the mechanism of complement-mediated virus neutralization. J. Virol 87:9250-9259
    5. Parks GD and Alexander-Miller MA. 2013. Invited Review: Paramyxovirus activation and inhibition of innate immune pathways. J. Molec. Biol. 425:4872-4892.
    6. Johnson JB, Lyles DS, Alexander-Miller MA and Parks GD. 2012. Virion-associated CD55 is more potent than CD46 in mediating resistance of mumps virus and VSV to neutralization. J. Virol. 86:9929-9940.
    7. Biswas, M, Kumar S, Johnson J, Parks GD and Subbiah E. 2012. Incorporation of host complement regulatory proteins into Newcastle Disease virus enhances complement evasion. J. Virol. 86:12708-12716.
    8. Briggs CM and Parks GD. 2012. Mumps virus inhibits migration of primary human macrophages toward a chemokine gradient through a TNF-alpha dependent mechanism. Virology 433:245-252.
    9. Johnson JB, Aguilar H, Lee B, and Parks GD. 2011. Interactions of human complement with virus particles containing the Nipah virus glycoproteins. J. Virol. 85:5940-5948.
    10. Clark KM, Johnson JB, Kock ND, Mizel SB and Parks GD. 2011. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus VACV antigens provide long-term protection in mice from lethal intranasal VACV challenge. Virology 419:97-106.
    11. Briggs CM, Holder RC, Reid SD and Parks GD. 2011. Activation of human macrophages by bacterial components relieves the restriction on replication of an interferon-inducing parainfluenza virus 5 (PIV5) P/V mutant. Microbes and Infection. 13:359-368.
    12. Manuse MJ and Parks GD. 2010. TLR3-dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5. Virology 397: 231-241.
    13. Armilli S, Sharma SK, Yammani R, Reid SD, Parks GD, and Alexander-Miller MA. 2010. Nonfunctional lung effectors exhibit decreased calcium mobilization associated with reduced expression of ORAI1. J. Leuk Biol. 87:977-88.
    14. Manuse MJ, Briggs CM, and Parks GD. 2010. Replication-Independent activation of human plasmacytoid dendritic cells by the paramyxovirus SV5 requires TLR7 and autophagy pathways. Virology 405:383-389.
View Full Profile
    Richard D. Peppler, Ph.D.
  • Title: Associate Dean, Faculty and Academic Affairs and Professor of Anatomy
  • Office: College of Medicine, 3rd Floor
  • Phone: 407.266.1101
  • Send an Email
  • Education:
    • B.A. Biology Gettysburg College
    • Ph.D. Anatomy University of Kansas


    • Anatomy
  • Biography:

    Dr. Dick Peppler was appointed Associate Dean for Faculty and Academic Affairs and Professor of Anatomy at the University of Central Florida College of Medicine in August 2007.   He was appointed as interim chair for the Department of Medical Education from 2007-2010 and served as interim director for the Burnett School for Biomedical Sciences from 2012-2014.  He received his BA from Gettysburg College and his PhD from the University of Kansas Medical Center, and was a faculty member at the LSU Medical Center, Quillen College of Medicine at ETSU and at the University of Tennessee Health Science Center before coming to UCF.

    At ETSU, he was founding faculty and Associate Chair of the Department of Anatomy, and at UT, he served as Associate Dean for Academic and Faculty Affairs for 22 years and as Dean of the College of Graduate Health Sciences for 10 years. As Dean, he was responsible for 7 graduate programs with over 350 graduate students and 400 graduate faculty. As the Associate Dean at UT, he was administratively responsible for over 2,100 faculty appointed in various positions and located at training sites throughout the state of Tennessee. He had direct responsibility in the College of Medicine for (1) the specific academic programs for 600 medical students; (2) the development and management of the curriculum; and (3) the processes of appointment, promotion and award of tenure for faculty. Peppler has over 75 publications in the area of reproductive physiology and medical education. He was recognized at ETSU in 1984 as a Distinguished Faculty Member and in 1994 by the University of Tennessee Alumni Association with their outstanding teaching award. In addition, he has received many teaching awards from students at LSU, ETSU and UT.

    Dick has served on the Southern Association of Colleges and Schools Reaffirmation Committees to the Medical College of Georgia, UT Southwestern, The Texas A&M Health Science Center, Texas Tech University Health Science Center, the University of Alabama at Birmingham, The University of Texas M.D. Anderson Cancer Center, the Medical University of South Carolina and the University of Texas Health Sciences Center at San Antonio; the latter seven of which he chaired.

    Dr. Peppler served on active duty during the Vietnam conflict at Fitzsimons General Hospital in Denver and during Operation Desert Storm at Fort Campbell, Kentucky. He retired in 1999 from the USAR with over 35 years of service.

View Full Profile
    Saleh M. M. Rahman, MD, Ph.D., M.P.H
  • Title: Assistant Dean for Diversity and Inclusion (Interim)
  • Office: 412-K
  • Phone: 407.266.1107
  • Send an Email
  • Education:
    • M.D., Sir Salimullah Medical College, Dhaka, Bangladesh
    • Post-Graduation Fellowship, Endocrinology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
    • M.P.H, Population and International Health, Harvard University School of Public Health, Boston, MA
    • Ph.D., Health Behavior, University of Alabama at Birmingham, Birmingham, AL


    • Behavioral Epidemiology
    • Global Health
    • Community Based Participatory Research (CBPR)
    • Health Disparities

    Research Interests:

    • Health disparity research
    • Cancer Prevention and Control
    • CBPR
    • Global Health
    • Medical Decision Analysis
  • Biography:

    Dr. Saleh Rahman received his Doctor of Medicine (M.B.B.S) degree from Sir Salimullah Medical College, Dhaka University, Bangladesh in 1992, Post-Graduation Fellowship in Endocrinology, Joslin Diabetes Center, Harvard Medical School under the International Diabetes Federation Short Training Fellowship Award in 1995, Master of Public Health degree from Harvard University School of Public Health in 1997 and Doctor of Philosophy degree from UAB School of Public Health in 2001.

    The UCF College of Medicine welcomed Dr. Rahman as a Professor of Medicine in July of 2016. Dr. Rahman is a member of the Medical Education department. He is responsible for integrating preventive and social medicine, epidemiology and biostatistics in particular, into the medical education curriculum.  He is actively involved in the Focused Inquiry and Research Experience in the first two years. Before joining UCF, Dr. Rahman previously taught as a Professor of Behavioral Science and Health Education at Florida A&M University, Clinical Research Professor of Medicine at Florida State University College of Medicine, served as the Director, Community outreach and Preventive Services Core, a NIH-funded P20 Center of Excellence for Cancer Research, Training and Community Service. During his time at FAMU, he was awarded the Public Health Teacher of the Year award in 2013, American Public Health Association-PHEHP Early Career Award in 2006, AACR Minority Serving Institution Faculty Scholar Award in 2008 and 2010. Dr. Rahman has professional experience in health disparity research, CBPR, Global Health, Diabetes prevention, HIV/STDs prevention, and cancer prevention and control.

    Dr. Rahman is a member of several professional organizations, including the American Association for Cancer Research (AACR), American Public Health Association (APHA) and the International Diabetes Federation (IDF). He serves as an Editorial Board Member of Universal Journal of Public Health and as a reviewer of numerous peer-reviewed journals. He is an elected Council of PHEHP Section and PHEHP Liaison to International Health Section of APHA. He has presented his research at numerous national, international and local conferences, and published scholarly articles in a variety of peer-reviewed scientific journals. Dr. Rahman is also a nationally awarded published author of his mother tongue, Bengali (pen-name: Sezan Mahmud) and so far published 27 books in his native language.


    Recent Publications

    1. Brown, J., Rahman SMM., et al., Community Intervention Increases Breast Cancer Knowledge among Underserved African-American Women, Health Education and Behavior (Under review)
    2. Kanninjing E., Rahman SMM., Close F., Pierre R., Dutton M., Lamango N., Onokpise O. Prostate cancer screening knowledge, attitudes, and beliefs among men in Bamenda, Cameroon. International Journal of Public Health and Epidemiology. Vol 6(4), pp 339-349, 2017.
    3. Sadiq B., Brown CP., Huffer FW., Onubogu U., Dutton M., Becker A., Rahman SMM., : Effect of Meteorological Variables on Malaria Incidence in Ogun State, Nigeria. International Journal of Public Health and Epidemiology. Vol 4(10), pp 205-15, 2015.
    4. Rahman SMM., Brown J., Rahman S., Vilme H., Hayes M.. Evaluation of community-based projects to reduce cancer disparities among underrepresented groups and participants satisfaction in health disparities projects. Cancer and Oncology Research, Vol.1(2): 55-64, 2013
    5. Rahman SMM., Rahman S., Vilme H., Hayes M. Closing the Gap: An evaluation of community-based projects to reduce diabetes disparities among minority and underrepresented groups. Universal Journal of Public Health, Vol. 1(3), 65-71, 2013.
    6. Boston PQ., Rahman SMM., Brown CP., Lopez IA., Musinggo M., Gadio CM., The Ability of Women to Overcome Household Food Insecurity: Social Support & Social Networks. Universal Journal of Public Health, Vol. 1(4), 166-171, 2013.
    7. Wilson M., Rahman SMM., Lopez IA., Kiros GE., Delores JCS., Dignan MB. Perceived Parental Support and Self-efficacy for Avoiding Sedentary Behaviors and Overweight Status among African American Children, Universal Journal of Public Health, Vol. 2(1), pp. 1 – 9 , 2014.
    8. Rahman SMM., Price JH., Dignan MB, Rahman S. et al., Access to Mammography Facilities and Breast Cancer Stage at Diagnosis Does geographic distance predict? International Journal of Cancer Prevention (IJCP), 2010. Vol.3 (3), 137-147.
    9. Rahman SMM, Rahman S. Breast cancer perceptions, knowledge and behavioral practices among women living in a rural community, International Journal of Cancer Prevention (IJCP), Vol.2 (6), 415-425 2008.
    10. Rahman S., Price JH., Dignan MB, Rahman SMM et al., Access to Mammography Facilities and Detection of Breast Cancer by Screening mammography: A GIS Approach. International Journal of Cancer Prevention (IJCP), Vol.2 (6), 403-414, 2008.
    11. Rahman S.,, Hu H., McNeely E., Peters J., Rahman SMM., Harris C. M., Harris C. H., Prothrow-Stith D., Krieger N., Gibbs B., Gragg R. D. Social and Environmental Determinants of Hypertension in African American. Florida Public Health Review, Vol. 5 (2), 64-72, 2008.
    12. Rahman S., Rahman SMM. Perceptions, Knowledge and Behavioral Practices Related to Screening Mammogram in Muslim Women. International Journal of Cancer Prevention (IJCP), Vol. 2 (4), 289-296, 2007.
View Full Profile
    Charles W. Roberts
  • Title: Assistant Vice President for Development
  • Office: College of Medicine, 3rd Floor
  • Phone: 407.266.1040
  • Send an Email
  • Education:

    B.A. English, University of the South

  • Biography:

    Charles W. (Chip) Roberts is the first development professional hired by the University of Central Florida College of Medicine and has served as the Assistant Vice President for Development since his hire in November 2007. His immediate assignment was to assist with the successful completion (over $7 million) of the Charter Class Scholarship Program, the first in the country ever to offer full scholarships to an entire class of medical students.

    Prior to that, Mr. Roberts served as the first Director of Development for the Everglades Foundation in Miami, Florida, where he planned and implemented one of the most successful fund raising events in Florida, raising over $2 million in its second year. He began his career in 1986 with the University of Miami, during its historic $517 million capital campaign; at the time, the second largest in the history of higher education. He then spent over nine years at Florida International University as a development officer overseeing several academic areas and as the Director of Corporate and Foundation Relations. He has served as the chief development officer at the Zoological Society of Florida, the YMCA of Greater Miami and Sunrise Community.

    Mr. Roberts is a member of the Association of Fundraising Professionals (AFP) of Central Florida and a past Vice President of AFP of Greater Miami. He is also a member of the Winter Park Rotary Club. A 1990 graduate of Leadership Miami, Mr. Roberts has presented fund raising topics to a number of community organizations, including Hands on Miami Leadership and the YMCA of Sao Paolo, Brasil. He is a graduate of The University of the South (Sewanee), with a degree in English literature. He and his wife Karen reside in Winter Springs, Florida with their four children.

View Full Profile
    Edward A. Ross, M.D., Chair
  • Title: Chair, Department of Internal Medicine and Professor of Internal Medicine
  • Office: College of Medicine, 3rd Floor
  • Phone: 407.266.1000
  • Send an Email
  • Education:
    • M.D., Boston University, Boston, MA
    • Resident, Vanderbilt University Medical Center, Nashville, TN
    • Fellow, Nephrology, University of California, Los Angeles and Veteran’s Affairs Wadsworth Hospital, Los Angeles, CA



    • Internal Medicine
    • Nephrology


  • Biography:

    Dr. Edward A. Ross received his M.D. degree from Boston University, completed his residency training at Vanderbilt University Medical Center, and received his fellowship training in nephrology at UCLA and the VA Wadsworth Hospital in Los Angeles. He is board certified in internal medicine and nephrology and has conducted research in the areas of renal dialysis, renal transplantation and hypertension.

    Dr. Ross’ laboratory research interests focus on biomaterials and engineering in regard to renal replacement therapies. Currently his group is studying organ regeneration by the use of pluripotent precursor cells seeded into decellularized intact kidneys. Mouse and rat models are utilized to investigate stem cell differentiation and remodeling of scaffold basement membranes, with xenotransplantation being the ultimate goal. Previous research efforts from his multidisciplinary group have included the invention and licensing of a polyethylene glycol technology that can be used therapeutically for immunoadsorption and diagnostically for the detection of trace quantities of toxins.

    Dr. Ross also has long-standing clinical research activity in improvements in extracorporeal renal replacement technology. His group has patented a safety device for detecting disconnection-associated venous hemorrhage in hemodialysis patients, as well as a photoplethysmography instrument to monitor vascular volume during ultrafiltration. Biomaterials and engineering projects have also included: the development bioimpedance technology for monitoring intra-abdominal fluid or hemorrhage; a new design for dialysis vascular access needles, and new phosphate-binding polymers. Direct clinical patient research studies have focused on the nutrition of dialysis patients. He has investigated the metabolism of a variety of nutrients, including pyridoxine, vitamin C, oxalate, glutathione, cysteine, and carnitine, and has published methods to improve nutrition in these patient populations.

    The University of Central Florida, College of Medicine welcomed Dr. Ross as the chair of Internal Medicine in the summer of 2014. In his role at UCF, Dr. Ross leads the Department of Internal Medicine and provides strategic leadership at UCF Pegasus Health, the college’s physician practice. Dr. Ross comes to UCF from the University of Florida, College of Medicine, where he was a tenured professor of medicine in the division of Nephrology, Hypertension and Renal Transplantation, director of the End Stage Renal Disease Program, and administrator of the Outpatient Chronic Dialysis Program at Shands Hospital. He also has served as vice chairman for clinical affairs in the Department of Medicine.


    Recent Publications

    Willenberg BJ, Batich CD, Oca-Cossio J, Clapp WL, Abrahamson DR, Terada N, Ellison GW, Mathews CE, ROSS EA. Repurposed biological scaffolds: Kidney to pancreas. Organogenesis. 2015; 11:47-57.

    Ayach T, Paugh-Miller JL, Nappo RW, ROSS EA. Postoperative hyperkalemia. Eur J Intern Med. 2015; 26:106-11.

    ROSS EA and Damman K. Management of refractory heart failure. In: RJ Johnson and J Feehally (Eds). Comprehensive Clinical Nephrology, 5th edition, Elsevier, Amsterdam, 2014; p.867-72.

    ROSS EA.   Congestive renal failure: The pathophysiology and treatment of renal venous hypertension. J Card Fail. 2012; 18:930-8.

    ROSS EA and Kazory A. Ultrafiltration therapy for cardiorenal syndrome: Physiologic basis and contemporary options. Blood Purif. 2012; 34:149-57.

    ROSS EA, Abrahamson DR, St. John P, Clapp WL, Williams MJ, Terada N, Hamazaki T, Ellison GW, Batich CD. Mouse stem cells seeded into decellularized rat kidney scaffolds endothelialize and remodel basement membranes. Organogenesis. 2012; 8:49-55.

    Alsabbagh M, Ejaz AA, Purich DL, ROSS EA. Regional citrate anticoagulation for slow continuous ultrafiltration: Risk of severe metabolic alkalosis. Clin Kidney J. 2012; 5:203-6.

    ROSS EA, Reisfield GM, Watson MC, Chronister CW, Goldberger BA. Psychoactive “Bath Salts” intoxication with methylenedioxypyrovalerone. Am J Med. 2012; 125:854-8.

    Sood P, Kumar G, Nanchal R, Sakhuja A, Ahmad S, Ali M, Kumar N, ROSS EA. Chronic kidney disease and end-stage renal disease predict higher risk of mortality in patients with primary upper gastrointestinal bleeding. Am J Nephrol. 2012; 35:216-24.

    Kazory A, Bellamy FB, ROSS EA. Ultrafiltration for acute decompensated heart failure: Financial implications. Int J Cardiol. 2012; 154:246-9.

    Kazory A and ROSS EA. Emerging therapies for heart failure: Renal mechanisms and effects. Heart Fail Rev. 2012; 17:1-16.

    ROSS EA. Evolution of treatment strategies for calciphylaxis. Am J Nephrol. 2011; 34:460-7.

    ROSS EA, Watson M, Goldberger B. “Bath salts” intoxication. N Engl J Med. 2011; 365:967-8.

    Branham ML, Govender T, ROSS EA. Beta-2 microglobulin removal by immunoextraction and passive adsorption in high-flux dialyzers. J Biomim Biomater Tissue Eng. 2011; 11:35-44.

    ROSS EA. What is the role for using sodium thiosulfate or bisphosphonates in the treatment of calciphylaxis? Semin Dial. 2011; 24:434-6.

    ROSS EA, Bellamy FB, Hawig S, Kazory A. Ultrafiltration for acute decompensated heart failure: Cost, reimbursement & financial impact. Clin Cardiol. 2011; 34:273-7.

    Branham ML and ROSS EA. Passive and facilitated transport of cyanocobalamin (Vitamin B12) across polymeric membranes in artificial kidneys. J Biomim Biomater Tissue Eng. 2011; 10:7-15.

    Singh RP, Derendorf H, ROSS EA. Simulation-based sodium thiosulfate dosing strategies for the treatment of calciphylaxis. Clin J Am Soc Nephrol. 2011; 6:1155-9.

    Sood P, Dass B, Bakuzonis C, ROSS EA. Intra-abdominal hypertension can be monitored with femoral vein catheters during CRRT and may cause access recirculation. Clin Nephrol. 2010; 74:223-8.

    ROSS EA and Bellamy FB. Reducing patient financial liability for hospitalizations: The physician role. J Hosp Med. 2010; 5:160-2.

    ROSS EA, Williams MJ, Hamazaki T, Terada N, Clapp WL, Adin C, Ellison GW, Jorgensen M, Batich CD. Pluripotent embryonic stem cells proliferate and differentiate when seeded into whole organ kidney scaffolds. J Am Soc Nephrol. 2009; 20:2338-47.

    Kazory A and ROSS EA. Ultrafiltration for decompensated heart failure: Renal implications. Heart. 2009; 95:1047-51.

    Kazory A and ROSS EA. Anemia: the point of convergence or divergence for kidney disease and heart failure? J Am Coll Cardiol. 2009; 53:639-47.

    Kazory A, Ejaz AA, ROSS EA. Ultrafiltration for heart failure: how fast should we move? Am Heart J. 2009; 157:205-7.

    Kazory A and ROSS EA. Contemporary trends in the pharmacological and extracorporeal management of heart failure: A nephrologic perspective. Circulation. 2008; 117:975-983.

    ROSS EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis. Am J Nephrol. 2008; 28:97-106.

    Fuehrlein B, Melker RB, ROSS EA. Alar photoplethysmography: A new methodology for monitoring fluid removal and carotid circulation during hemodialysis. J Clin Monit Comput. 2007; 2007; 21:211–218.

    ROSS EA, Scott WE III, Odukale AA, Alba NA, Batich CD. Transient acid exposure increases Sevelamer HCl phosphate binding. J Pharm Sci. 2007; 96:2154-60.

    ROSS EA, Alza RE, Jadeja NN. Hospital resource utilization that occurs with, rather than because of, kidney failure in patients with end-stage renal disease. Clin J Am Soc Nephrol. 2006; 1:1234-1240.

    ROSS EA, Briz C, Sadleir JR. Method for detecting the disconnection of an extracorporeal device using a patient’s endogenous electrical voltages”. Kidney Int. 2006; 69:2274-7.

    ROSS EA, Hollen TL and Fitzgerald BM. Observational study of an Arts-In-Medicine program in an outpatient hemodialysis unit. Am J Kidney Dis. 2006; 47:462-8.

    Bihorac A and ROSS EA. Continuous venovenous hemofiltration with citrate-based replacement fluid: Efficacy, safety, and impact on nutrition. Am J Kidney Dis. 2005; 46:908-918.

    ROSS EA, Savage KA, Utley LJ, Tebbett IR.   Insect repellent interactions: Sunscreens enhance DEET (N,N-diethyl-M-toluamide) absorption. Drug Metab Dispos 2004;32:783-785.

    ROSS EA, Batich CD, Clapp WL, Sallustio JE, Lee NC. Tissue adhesion to bioactive glass-coated silicone tubing in a rat model of peritoneal dialysis catheters and catheter tunnels. Kidney Int 2003;63:702-708.

    ROSS EA, Pittman TB, Koo LC. Strategy for the treatment of noncompliant hypertensive hemodialysis patients. Int J Artif Organs 2002;25:1061-1065.

    ROSS EA, Branham ML, Tebbett IR. High mass clearance of autoantibodies from a murine model of lupus nephritis by immunoadsorption using star-configured polyethylene glycols. J Biomed Mater Res 2001;55:114-120.

    ROSS EA, Szabo NJ, Tebbett IR. Lead content of calcium supplements. JAMA 2000; 284:1425-1429.

    ROSS EA, Verlander JW, Koo LC, Hawkins IF. Minimizing hemodialysis vascular access trauma with an improved needle design. J Am Soc Nephrol 2000; 11:1325-1330.

    ROSS EA, Branham ML, Tebbett IR. Optimization of ligand presentation for immunoadsorption using star-configured polyethylene glycols. J Biomed Mater Res 2000; 51:29-36.

    ROSS EA and Koo LC. Improved nutrition after the detection and treatment of occult gastroparesis in nondiabetic dialysis patients. Am J Kidney Dis 1998; 31:62-66.

    ROSS EA, Koo LC, Moberly JB. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1997; 30:489-494.

    Rutledge DR, Sun Y, ROSS EA. Polymorphisms within the atrial natriuretic peptide gene in essential hypertension. J Hypertens 1995; 13:953-955.

    Rutledge DR, Kubilis P, Browe CS, ROSS EA. Polymorphism of the angiotensin I converting enzyme gene in essential hypertensive patients. Biochem Molecular Biol Intl 1995; 35:661-668.

    Rutledge DR, Browe CS, ROSS EA. Frequencies of the angiotensinogen gene and angiotensin I converting enzyme (ACE) gene polymorphisms in African Americans African Americans. Biochem Molecular Biol Intl 1994; 34:1271-1275.

    Rutledge DR, Browe CS, Kubilis P, ROSS EA. Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans. Am J Hypertension 1994; 7:651-654.


View Full Profile
    Wendy Sarubbi
  • Title: Assistant Vice President for Communications and Marketing, Health Affairs
  • Phone: 407.266.1418
  • Send an Email
  • Education:

    Ohio Wesleyan University, B.A.

  • Biography:

    Wendy Spirduso Sarubbi is Assistant Vice President, Communications and Marketing for Health Affairs at the University of Central Florida College of Medicine. Wendy joined the new medical school in 2010 after 30 years in news media and corporate communications.

    Prior to coming to UCF, Wendy was director/manager of communications for Darden Restaurant’s Red Lobster chain, the world’s largest casual dining seafood restaurant. There she was the company’s chief spokesman and managed media relations for 680 restaurants in North America with annual sales of $2.6 billion.

    She spent 23 years at the Tribune Company’s Orlando Sentinel, where she was an award-winning writer and editor. She started as an education reporter and then took on roles of increasing responsibility. Wendy served on the Editorial Board, helping to determine the newspaper’s positions on international, federal, state and local issues. She served as the paper’s first Orange County editor, overseeing news coverage of the largest area in the Sentinel’s circulation area. She also served as editor of Florida magazine, making it one of the few Sunday newspaper magazines in the nation to be financially profitable.

    Wendy received her B.A. degree in journalism and speech from Ohio Wesleyan University, where she graduated magna cum laude and Phi Beta Kappa.

View Full Profile
    Jeanette C. Schreiber, JD, MSW
  • Title: Associate Vice President for Medical Affairs and Chief Legal Officer
  • Office: College of Medicine, 3rd Floor
  • Phone: 407.266.1000
  • Send an Email
  • Education:
    • B.A. magna cum laude, Emory University, Atlanta, Georgia
    • M.S.W. highest honors, Florida State University School of Social Work
    • J.D. cum laude, Harvard Law School
    • Board certified in Health Law by the Florida Bar; admitted to practice in Florida and Connecticut
View Full Profile
    Basma Selim, Ph.D.
  • Title: Assistant Dean of Planning and Knowledge Management
  • Office: 313F
  • Phone: 407.266.1411
  • Biography:

    Basma Selim, Ph.D., is Assistant Dean of Planning and Knowledge Management, leading strategic planning educational technology, assessment, knowledge management and data collection at the medical school.

    She is a founding staff member at the College of Medicine, having joined the medical school in 2007 – a year after its approval. She has held a variety of leadership positions in accreditation, planning and assessment. Before becoming Assistant Dean, she served as executive director of planning and knowledge management, director of analysis, planning and accreditation, and director of assessment.

    Dr. Selim earned her doctorate and M.S. degrees in industrial engineering from UCF after graduating from the American University in Cairo, Egypt with a bachelor’s degree in mechanical engineering.

View Full Profile
    Judith S. Simms-Cendan, M.D.
  • Title: Professor of Obstetrics and Gynecology, President of the Faculty Council
  • Office: College of Medicine, 4th Floor
  • Phone: 407.266.1171
  • Send an Email
  • Education:
    • B.S., Biochemistry, University of Miami, Coral Gables, Florida
    • M.D., University of Florida College of Medicine, Gainesville, Florida
    • Residency in Obstetrics and Gynecology, University of Florida, Gainesville, Florida


    • Obstetrics and Gynecology
    • Pediatric and Adolescent Obstetrics and Gynecology
  • Biography:


    Dr. Judy Simms-Cendan is a Professor of Obstetrics and Gynecology and Director of International Experiences at the University of Central Florida College of Medicine. She enjoys the full spectrum of clinical practice, education, research and service.


    She is a 1991 graduate of the University of Florida College of Medicine and completed her residency training in Obstetrics and Gynecology there in 1995. She remained on the faculty at UF until joining the founding faculty at the University of Central Florida College of Medicine in 2010. She is active in providing content throughout the integrated curriculum, especially in the Endocrine and Reproductive Module for the second-year students. She is also the co-Director of the Interprofessional Education Longitudinal Curricular program. She is fluent in Spanish and directs the Medical Spanish 4th year elective.


    Dr. Simms-Cendan and her partner run the only clinic in central Florida focused on Pediatric and Adolescent Gynecology; she opened the first clinics dedicated to these patients in 2010 at Winnie Palmer Hospital. She is a very active in the North American Society of Pediatric Adolescent gynecology, having served on the Board of Directors, as co-Chair of the Education Committee and as the 2017 annual meeting chair. She has written clinical guidelines for the society in addition to other publications in the specialty. She is on the ACOG Adolescent Committee and involved in writing Committee Opinions in Pediatric Adolescent Gynecology.


    Dr. Simms-Cendan has been involved in international medical education for over 15 years. Her work has included reproductive medicine education at medical schools in Ethiopia. Her current work includes directing a medical/surgical program in Yantalo, Peru. Her experience has led her to develop a glocal” program to serve the farmworkers in central Florida. She is the advisor for the global health medical student interest group MedPACt, which hosts an annual Global Health Conference attended by students and faculty from across the state. She provides guidance for all students participating in international medical electives. Her research in global health includes effective teaching strategies at medical schools in developing countries and the long-term educational value of student participation in international medical programs.


    Dr. Simms-Cendan helped establish the Knights Student Run Free Clinic at Grace Medical Home in 2013 and serves as a Faculty Advisor for the students. In this role she assists with faculty recruitment, research, organization, and fundraising. The Knights clinic includes community as well as COM core faculty, and is expanding its interdisciplinary structure to include pharmacy students and nursing students.  The innovative programs have recently been presented at national meetings and the Knights clinic board is now helping other new medical schools establish their own clinic.



    • Bercaw, JL, Boardman LA, Simms-Cendan, J. Clinical Recommendation: Pediatric Lichen Sclerosus (2014) Journal of Pediatric Adolescent Gynecology,
    • Simms-Cendan J, Cendan J, Boardman L, Voorhees D, Eakins M, Merritt D. The Clinical Breast Exam: A Video and Animation Enhanced Self-learning Module . MedEdPORTAL; 2012. Available from:
    • Jackson MG, Simms-Cendan JS, Sims SM, McLean FW, Roscoe J, Ross HL, Davis JD.  Vaginal Bleeding Due to an Infantile Hemangioma in a Three-Year-Old Girl.  J Pediatr Adolesc Gynecol 2009 (August); 22:e53-e55.
    • Simms-Cendan JS. Alternative Medicine During the Perimenopause. In Novi JM, Ross HL (eds): Perimenopause. New York, NY, Informa Healthcare Publishing Inc, August 30, 2008.
    • Jackson MG, Simms-Cendan JS, Sims SM, McLean FW, Roscoe J, Ross HL, Davis JD. Vaginal Bleeding Due to an Infantile Hemangioma in a Three-Year-Old Girl. J Pediatric Adolescent Gynecol 2008.
View Full Profile
    Karen Smith
  • Title: Director, Administrative Services, Special Assistant to the Vice President for Medical Affairs and Dean, College of Medicine
  • Phone: 407.266.1003
  • Send an Email
  • Education:
    • B.A., M.S. Ed., Purdue University
  • Biography:

    Karen is the Director of Administrative Services and Special Assistant to the Vice President for UCF Medical Affairs and Dean, College of Medicine, serving as a representative and ambassador for the medical school to both internal and external partners in a variety of academic, healthcare, corporate, and community settings.

    In her roles, Karen is responsible for directing communications to and from the office of the VP/Dean; and initiating, planning, executing, and monitoring daily operations, including the annual college meetings and events as requested by the VP/Dean.

    Karen joined the medical school in July 2008 and is the first to serve as Special Assistant to the Vice President/Dean. Prior to joining the medical school, and over the previous 25 years, Karen has served as a District Manager and Corporate Trainer/Advisor of new business start-ups and day-to-day operations for a division of United Health Care; an educator of students in grades 1 – 5, with two years specializing in the gifted and talented program; and Operations Manager for a leading K-12 publishing company. She is also Lean SS certified.

    Karen earned her undergraduate degree and M.S. Ed. degree in University Administration from Purdue University. During her tenure as an educator for the Lafayette School Corporation, Indiana, Karen served as a liaison between the School Corporation and Purdue University for the Purdue Student Teacher Placement Program. She also mentored the student teachers, monitored their progress and provided performance feedback to both the students and the university.

    Karen and her husband Jim reside in Orlando, Florida.


View Full Profile
    Marcia L. Verduin, M.D.
  • Title: Associate Dean, Students and Professor of Psychiatry
  • Office: College of Medicine, 1st Floor
  • Phone: 407.266.1353
  • Send an Email
  • Education:
    • B.A. Chemistry, New College of Florida
    • M.D. with Honors, University of Florida College of Medicine
    • Psychiatry Residency, Medical University of South Carolina
    • Chief Resident in Psychiatry, Medical University of South Carolina
    • Post-doctoral Research Fellowship (funded by the National Institute on Drug Abuse), Medical University of South Carolina
    • Addiction Psychiatry Fellowship, Medical University of South Carolina


    • Psychiatry
  • Biography:

    Dr. Marcy Verduin is board-certified in Adult Psychiatry with added qualifications in Addictions. She has extensive experience with medical education, research and clinical practice, having served on the faculty at the Medical University of South Carolina in Charleston prior to joining the UCF College of Medicine. Her clinical and research interests include severe mental illness co-occurring with substance use disorders, with a primary focus on schizophrenia and bipolar disorder. She has served as the Principal Investigator or a Co-Investigator on several clinical and human laboratory trials, including a Career Development (K23) Award through the National Institute on Drug Abuse. Dr. Verduin has also held speaking engagements at national symposia and has served on the American Psychiatric Association’s Corresponding Committee on Training and Education in Addiction Psychiatry.

    Dr. Verduin joined the UCF College of Medicine in August of 2007 as the Module Director for the Psychosocial Issues in Healthcare Module and the Director of the Psychiatry Clerkship (C-1). She now serves as an educator for the C-1 module and contributes to the development and implementation of the Mind and Body Module in Year 2, with a focus on psychopathology. She also plays a role in Student Affairs as the Associate Dean for Students.

    Dr. Verduin was the Principal Investigator on a Robert Wood Johnson Foundation grant to design and examine the effect of interactive video games to help recovering alcoholics practice their relapse prevention skills. Her clinical work is based out of the Orlando VA Medical Center, where she is the Attending Psychiatrist for the Substance Abuse Residential Rehabilitation Treatment Program. She also serves as the Associate Book Editor for the Journal of Psychiatric Practice, on the Editorial Board for the FOCUS Self-Assessment Examination, and as an Ad Hoc Reviewer for several psychiatric and addictions journals.


    McRae AL, Verduin ML, Tolliver BK, Carter RE, Herrin AE, Brady KT, Anderson SJ. An open-label trial of aripiprazole treatment in dual diagnosis individuals: safety and efficacy. J Dual Diagn, in press.

    Tolliver BK, McRae AL, Verduin ML, Anderson SJ, Brady KT. Reversible elevation of triglycerides in dual diagnosis patients taking aripiprazole: a case series. J Clin Psychopharmacol 2008;28(4):464-7.

    Gao K, Verduin ML, Kemp DE, Tolliver B, Ganocy SJ, Elhaj O, Brady K, Findling RL, Calabrese JR. Clinical Correlates of Patients with Rapid Cycling Bipolar Disorder and a Recent History of Substance Use Disorder: a Subtype Comparison. J Clin Psychiatry 2008;69(7):1057-63.

    Brady KT, Verduin ML, Tolliver BK. Treatment of patients comorbid for addiction and other psychiatric disorders. Curr Psychiatry Rep 2007;9(5):374-80.

    Verduin ML, Upadhyaya H. Beating nicotine: medication algorithm helps teens quit. Current Psychiatry 2007;6(10):65-74.

    Verduin ML. Ask the expert: treatment strategy for co-occurring bipolar disorder and alcohol abuse. FOCUS 2007;V(2):170-1.

    Verduin ML, Payne RA, McRae AL, Back SE, Simpson SA, Sarang RY, Brady KT. Assessment of club drug use in a treatment-seeking sample of individuals with marijuana dependence. Am J Addict 2007;16:1-4.

    Verduin ML, McKay S, Brady KT. Gabapentin in comorbid anxiety and substance use. Am J Addict 2007;16:1-2.

    Brady KT, Tolliver BK, Verduin ML. Alcohol use and anxiety: diagnostic and management issues. Am J Psychiatry 2007;164:217-21.

    Brady KT, Verduin ML. Pharmacotherapy of co-morbid mood, anxiety, and substance use disorders. Subst Use Misuse 2005; 40:2021-41.

    Verduin ML, Carter RE, Brady KT, Myrick H, Timmerman M. Health service use among persons with comorbid bipolar and substance use disorders. Psychiatr Serv 2005; 56(4):475-80.


    • Early Career Investigator Award, College on Problems of Drug Dependence
    • Laughlin Fellow, American College of Psychiatrists
    • Ginsberg Fellow, American Association of Directors of Psychiatric Residency Training
    • PRITE Fellow, American College of Psychiatrists
    • Golden Apple Award for Outstanding Lecturer in the Psychiatry Clerkship at the Medical University of South Carolina, 7 consecutive years
View Full Profile
    Loui Abdelghani, MD
  • Specialization: Internal Medicine
  • Degree: Doctor of Medicine
  • Appointment Level: Assistant Professor
    Melissa D. Abercrombie, DPM
  • Specialization: Surgery
  • Degree: Doctor of Podiatric Medicine
  • Appointment Level: Instructor
    John H Abernethy, MD
  • Specialization: Family Medicine
  • Degree: Doctor of Medicine
  • Appointment Level: Assistant Professor
1 2 3 108